Company Search:
Advanced Search
Sponsored Links
Wakamoto Pharmaceutical Co., Ltd. Company Snapshot
Wakamoto Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Wakamoto Pharmaceutical Co., Ltd. with three other companies in this sector in JAPAN : Biofermin Pharmaceutical Company Limited (2020 sales of 11.92 billion Japanese Yen [US$114.36 million] of which 63% was New BioferminS), I'rom Group Co Ltd (10.59 billion Japanese Yen [US$101.59 million] of which 59% was Smo Business), and Taiko Pharmaceutical Company., Limited (14.97 billion Japanese Yen [US$143.53 million] of which 62% was Infection Control).

Sales Analysis. Wakamoto Pharmaceutical Co., Ltd. reported sales of ¥10.92 billion (US$104.69 million) for the fiscal year ending March of 2020. This represents a very small increase of 1.6% versus 2019, when the company's sales were ¥10.74 billion. The sales level in 2020 was fairly close to the level five years ago: in 2015, Wakamoto Pharmaceutical Co., Ltd. had sales of ¥10.62 billion. Sales of Healthcare Bussiness saw an increase that was more than double the company's growth rate: sales were up 14.4% in 2020, from ¥3.07 billion to ¥3.52 billion. Not all segments of Wakamoto Pharmaceutical Co., Ltd. experienced an increase in sales in 2020: sales of Medical Pharmaceutical Products fell 3.9% to ¥6.57 billion. Wakamoto Pharmaceutical Co., Ltd. also experienced decreases in sales in International Bussiness (down 0.8% to ¥639.85 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Wakamoto Pharmaceutical Co., Ltd.
  Stock Performance Chart for Wakamoto Pharmaceutical Co., Ltd.
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 261.00
(Figures in Japanese Yen )
1 Week 0.0%   13 Weeks -8.7%  
4 Weeks -2.6%   52 Weeks -5.4%  
Wakamoto Pharmaceutical Co., Ltd. Key Data:
  Ticker: 4512 Country: Japan
  Exchanges: TYO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 10,916,899,000
(Year Ending Jan 2021).
Employees: 315
  Currency: Japanese Yen Market Cap: 9,058,718,574
  Fiscal Yr Ends: March Shares Outstanding: 34,707,734
  Share Type: Common Closely Held Shares: 13,231,037
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.